Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vicenç Falcó

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
Expert Opinion on Pharmacotherapy|January 21, 2020
An overview of lefamulin for the treatment of community acquired bacterial pneumoniaVicenç Falcó, Joaquin Burgos, Benito Almirante
AIDS Reviews|July 30, 2011
Antiretroviral salvage therapy for multiclass drug-resistant HIV-1-infected patients: from clinical trials to daily clinical practiceArkaitz Imaz, Vicenç Falcó, Esteban Ribera
AIDS Reviews|January 26, 2018
Antiretroviral Therapy in Advanced HIV Disease: Which is the Best Regimen?Joaquin Burgos, Esteban Ribera, Vicenç Falcó
Expert Opinion on Pharmacotherapy|July 25, 2003
Lactic acidosis related to nucleoside therapy in HIV-infected patientsVicenç Falcó, Manuel Crespo, Esteban Ribera
Expert Opinion on Pharmacotherapy|January 8, 2019
Chemical pharmacotherapy for hospital-acquired pneumonia in the elderlyJoaquin Burgos, Vicenç Falcó, Benito Almirante
Expert Opinion on Pharmacotherapy|September 11, 2018
Ceftobiprole medocaril for the treatment of community-acquired pneumoniaVicenç Falcó, Joaquin Burgos, Benito Almirante
Current Opinion in Pulmonary Medicine|March 20, 2013
The increasing incidence of empyemaJoaquín Burgos, Vicenç Falcó, Albert Pahissa
Expert Opinion on Emerging Drugs|April 14, 2011
Emerging drugs for pneumococcal pneumoniaVicenç Falcó, Ana Sánchez, Albert Pahissa, et al.
AIDS Reviews|December 22, 2012
Management of tuberculosis in HIV-infected patientsAdrian Curran, Vicenç Falcó, Albert Pahissa, et al.
Journal of Experimental Pharmacology|November 26, 2020
Investigational and Experimental Drugs for Community-Acquired Pneumonia: the Current EvidenceJuilia Sellarès-Nadal, Joaquin Burgos, Vicenç Falcó, et al.
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Expert Opinion on Pharmacotherapy|January 21, 2020
An overview of lefamulin for the treatment of community acquired bacterial pneumoniaVicenç Falcó, Joaquin Burgos, Benito Almirante
AIDS Reviews|July 30, 2011
Antiretroviral salvage therapy for multiclass drug-resistant HIV-1-infected patients: from clinical trials to daily clinical practiceArkaitz Imaz, Vicenç Falcó, Esteban Ribera
AIDS Reviews|January 26, 2018
Antiretroviral Therapy in Advanced HIV Disease: Which is the Best Regimen?Joaquin Burgos, Esteban Ribera, Vicenç Falcó
Expert Opinion on Pharmacotherapy|July 25, 2003
Lactic acidosis related to nucleoside therapy in HIV-infected patientsVicenç Falcó, Manuel Crespo, Esteban Ribera
Expert Opinion on Pharmacotherapy|January 8, 2019
Chemical pharmacotherapy for hospital-acquired pneumonia in the elderlyJoaquin Burgos, Vicenç Falcó, Benito Almirante
Expert Opinion on Pharmacotherapy|September 11, 2018
Ceftobiprole medocaril for the treatment of community-acquired pneumoniaVicenç Falcó, Joaquin Burgos, Benito Almirante
Current Opinion in Pulmonary Medicine|March 20, 2013
The increasing incidence of empyemaJoaquín Burgos, Vicenç Falcó, Albert Pahissa
Expert Opinion on Emerging Drugs|April 14, 2011
Emerging drugs for pneumococcal pneumoniaVicenç Falcó, Ana Sánchez, Albert Pahissa, et al.
AIDS Reviews|December 22, 2012
Management of tuberculosis in HIV-infected patientsAdrian Curran, Vicenç Falcó, Albert Pahissa, et al.
Journal of Experimental Pharmacology|November 26, 2020
Investigational and Experimental Drugs for Community-Acquired Pneumonia: the Current EvidenceJuilia Sellarès-Nadal, Joaquin Burgos, Vicenç Falcó, et al.
Pageof 11